Cambridge Cancer Genomics
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.
Funding reportedLast round: Seed
What company datasets say Cambridge Cancer Genomics raised
Funding, as reported
Reported in all8.5Min the source's currency
Rounds3
Last roundSeed
Last round dateDec 2018
Investors listed10
Y CombinatorS17
On a portfolio page
Investors who name them
Each firm lists Cambridge Cancer Genomics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Cambridge Cancer Genomics in front of investors. Or tell us what we have wrong.